geographic atrophy
Showing 51 - 74 of 74
Geographic Atrophy, Age Related Macular Degeneration Trial in Australia, New Zealand, United States (IONIS-FB-Lrx, Placebo
Withdrawn
- Geographic Atrophy
- Age Related Macular Degeneration
- IONIS-FB-Lrx
- Placebo (sterline saline 0.9%)
-
Phoenix, Arizona
- +36 more
Aug 9, 2019
Geographic Atrophy Secondary to Age-Related Macular Degeneration
Terminated
- Geographic Atrophy
- No intervention
-
Pensacola, Florida
- +62 more
Aug 7, 2019
Geographic Atrophy Trial in Worldwide (Lampalizumab, Sham)
Geographic Atrophy, Macular Degeneration Trial in Worldwide (400 µg Brimonidine Implant, Sham)
Terminated
- Geographic Atrophy
- Macular Degeneration
- 400 µg Brimonidine Implant
- Sham
-
Phoenix, Arizona
- +40 more
Mar 29, 2019
Geographic Atrophy Trial in Lexington (RNA-144101)
Withdrawn
- Geographic Atrophy
-
Lexington, KentuckyUniversity of Kentucky / Dept of Ophthalmology
Jan 15, 2018
Visual Acuity, Geographic Atrophy, Macular Degeneration Trial in Japan (CNTO 2476 (6.0 * 10^4 cells), CNTO 2476 (3.0 * 10^5
Withdrawn
- Visual Acuity
- +2 more
- CNTO 2476 (6.0 * 10^4 cells)
- CNTO 2476 (3.0 * 10^5 cells)
-
Chiyoda, Japan
- +7 more
Dec 21, 2017
Precision of the Microperimetry Function of the Spectral OCT/SLO
Completed
- Age-Related Macular Degeneration
- +8 more
-
Fort Lauderdale, Florida
- +2 more
Apr 3, 2017
Sparing of the Fovea in Geographic Atrophy Progression
Completed
- Atrophy
- +3 more
- No intervention - Natural history study
-
Bonn, NRW, GermanyDepartment of Ophthalmology, University of Bonn
May 5, 2017
Human Central Nervous System Stem Cells in Geographic Atrophy of
Terminated
- Age-Related Macular Degeneration
- Geographic Atrophy
- Human Central Nervous System Stem Cells
-
Dallas, TexasRetina Foundation of the Southwest
May 31, 2016
Geographic Atrophy, Age-Related Macular Degeneration Trial in Seattle (Emixustat HCl Tablet, Placebo Tablet)
Completed
- Geographic Atrophy
- Age-Related Macular Degeneration
- Emixustat HCl Tablet
- Placebo Tablet
-
Seattle, WashingtonCall Acucela Clinical Trials Helpdesk for locations
Jan 14, 2016
Associated With Geographic Atrophy Progression
Completed
- Geographic Atrophy
-
Barcelona, SpainInstitut de la màcula i de la retina
Mar 23, 2015
Geographic Atrophy and Intravitreal Ranibizumab Injections
Unknown status
- Age-related Macular Degeneration
- Geographic Atrophy
-
Toronto, Ontario, CanadaToronto Western Hospital
Feb 25, 2015
Geographic Atrophy, Age-Related Macular Degeneration Trial (AL-8309B Ophthalmic Solution, AL-8309B Vehicle)
Terminated
- Geographic Atrophy
- Age-Related Macular Degeneration
- AL-8309B Ophthalmic Solution
- AL-8309B Vehicle
- (no location specified)
Jun 4, 2014
Dry Age-related Macular Degeneration, Geographic Atrophy Trial in United States (ACU-4429, Matching )
Completed
- Dry Age-related Macular Degeneration
- Geographic Atrophy
- ACU-4429
- Matching placebo
-
Phoenix, Arizona
- +11 more
Feb 7, 2014
Geographic Atrophy Trial (Al-78898A, Sham injection)
Area of Increased Light Penetration Under Retinal Pigment
Completed
- Age Related Macular Degeneration
- Geographic Atrophy
-
Oakland, California
- +1 more
Dec 17, 2013
Macular Choroidal Neovascularization in a Chinese Population
Completed
- Geographic Atrophy
- +2 more
- Follow-up observation
-
Shanghai, Baoshan District, ChinaYouyi Street
Aug 14, 2012
Geographic Atrophy, Dry Age Related Macular Degeneration Trial (Fenretinide)
Completed
- Geographic Atrophy
- Dry Age Related Macular Degeneration
- (no location specified)
Jun 21, 2010
Geographic Atrophy Progression (GAP) Study
Terminated
- Age-Related Macular Degeneration
- Geographic Atrophy
-
Houston, TexasHouston
Feb 26, 2010